Table 2:
Variables* | BCR/Total N | HR | 95% Cl | P |
---|---|---|---|---|
Undetectable PSA nadir | ||||
TTN 3–6 months | 28/130 | ref | - | - |
TTN 1–2.99 months | 317/1537 | 0.86 | 0.58–1.28 | 0.462 |
Detectable PSA nadir | ||||
TTN 3–6 months | 36/86 | 1.81 | 1.08–3.03 | 0.024 |
TTN 1–2.99 months | 110/186 | 3.75 | 2.44–5.74 | <0.001^ |
Analysis adjusted for race, body-mass index, age, year, VA medical center, preoperative PSA, pathological Gleason score, surgical margins, seminal vesicle invasion and extracapsular extension
Among those with a detectable PSA nadir, those with TTN 1–2.99 months have significantly higher risk of recurrence compared to those with TTN 3–6 months (p<0.001)
HR: Hazard ratio
CI: Confidence interval
TTN: time to nadir